Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
AMEX
Rexahn Pharmaceuticals, Inc. (RNN)
Rexahn Pharmaceuticals, Inc. (RNN) News

RNN

Rexahn Pharmaceuticals, Inc. (RNN)

Rexahn Pharmaceuticals, Inc.

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:RNN

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 Next >>

Date	Time	Source	Headline	Symbol	Company
10/15/2013	5:03PM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
10/11/2013	9:00AM	Business Wire	Rexahn Announces $5.3 Million At Market Registered Direct Offering	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
10/10/2013	8:00AM	Business Wire	Rexahn Pharmaceuticals In-Licenses Novel Oligonucleotide Targeted Drug Delivery Platform from Ohio State University	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
10/09/2013	4:13PM	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
09/30/2013	8:00AM	Business Wire	Rexahn Pharmaceuticals Announces Publication of Preclinical Data for Novel Anti-Cancer Compound RX-3117	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
09/30/2013	8:00AM	Business Wire	Rexahn Pharmaceuticals Announces Publication of Preclinical Data for Novel Anti-Cancer Compound RX-3117	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
09/12/2013	8:00AM	Business Wire	Rexahn Awarded Patent in Europe for Cancer Drug Archexin®	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
09/11/2013	6:02PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
09/05/2013	8:00AM	Business Wire	Rexahn Pharmaceuticals to Present at the 15th Annual Rodman & Renshaw Global Investment Conference on September 9, 2013	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
09/04/2013	8:00AM	Business Wire	Rexahn Pharmaceuticals Provides a Clinical Development and Financial Update	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
08/29/2013	4:21PM	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
08/28/2013	9:00AM	Business Wire	Rexahn Pharmaceuticals Announces Teva will not Exercise its Option to License RX-3117	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
08/28/2013	9:00AM	Business Wire	Rexahn Pharmaceuticals Announces Teva will not Exercise its Option to License RX-3117	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
08/07/2013	8:00AM	Business Wire	Rexahn Pharmaceuticals Initiates Dosing in Phase I Trial of SupinoxinTM (RX-5902) a Candidate for Treating Solid Cancer Tumors	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
07/24/2013	5:20PM	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
07/24/2013	5:12PM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
07/24/2013	9:00AM	Business Wire	Rexahn Pharmaceuticals Announces $5.7 Million Registered Direct Offering	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
07/17/2013	8:00AM	Business Wire	Rexahn Pharmaceuticals In-Licenses Breakthrough Oncology Drug Delivery Platform	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
07/15/2013	4:15PM	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
07/15/2013	8:00AM	Business Wire	Rexahn Pharmaceuticals Announce IND Submission for RX-3117	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
07/09/2013	8:00AM	Business Wire	Rexahn Pharmaceuticals Awarded Patent in Japan for Novel Anti-cancer Isoquinolinamine Compounds	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
06/17/2013	8:00AM	Business Wire	Rexahn Awarded U.S. Patent for Novel Anti-Cancer Compounds	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
06/13/2013	4:45PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
06/13/2013	4:41PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
06/13/2013	4:34PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
06/13/2013	4:28PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
06/13/2013	4:23PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
06/11/2013	5:12PM	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
06/11/2013	4:58PM	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
05/20/2013	8:00AM	PR Newswire (US)	Rexahn Pharmaceuticals To Present At The Second Annual Marcum LLP MicroCap Conference	AMEX:RNN	Rexahn Pharmaceuticals, Inc.

Showing the most relevant articles for your search:AMEX:RNN

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 Next >>

New Momentum (PK)

Cann American (CE)

Therapeutic Solutions (PK)

RespireRx Pharmaceuticals (PK)

Elite Pharmaceuticals (QB)

Rennova Health (PK)

Asia Broadband (PK)

Bell Buckle (PK)

Progressive Care (QB)

Gold and GemStone Mining (PK)

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions